The Application of Cost-Effectiveness and Cost–Benefit Analysis to Pharmaceuticals. Ricos Biology, [S. l.], v. 2, n. 2, p. 59–70, 2024. DOI: 10.33687/ricosbiol.02.02.0032. Disponível em: https://ricosbiology.net/index.php/journal/article/view/32. Acesso em: 20 dec. 2024.